Robert DeCresce

Chairperson, Pathology at Rush University Medical Center

Robert DeCresce

Robert DeCresce

Chairperson, Pathology at Rush University Medical Center

Overview
RelSci Relationships

1543

Number of Boards

5

Birthday

1950

Age

70

Contact Data
Trying to get in touch with Robert DeCresce? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Robert DeCresce likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Chief Executive Officer at Rush University Medical Center

Relationship likelihood: Strong

Advisor at WHI Capital Partners

Relationship likelihood: Strong

Chief Nursing Officer & Senior Vice President of Hospital Operations at Rush University Medical Center

Relationship likelihood: Strong

Former President, Medical Staff at Rush University Medical Center

Relationship likelihood: Strong

President, Rush Medical Staff at Rush University Medical Center

Relationship likelihood: Strong

Acting Dean, Rush Medical College at Rush University Medical Center

Relationship likelihood: Strong

Director-Pulmonary & Critical Care Medicine at Rush University Medical Center

Relationship likelihood: Strong

Interim Dean, Ended at Rush University Medical Center

Relationship likelihood: Strong

Executive Vice President & Chief Financial Officer at Univar Solutions, Inc.

Relationship likelihood: Strong

Industry Advisor at Madison Dearborn Partners LLC

Relationship likelihood: Strong

Paths to Robert DeCresce
Potential Connections via
Relationship Science
You
Robert DeCresce
Chairperson, Pathology at Rush University Medical Center
Education
Career History
Chairperson, Pathology
1991 - Current

Rush is a not-for-profit academic medical center comprising Rush University Medical Center, Rush University, Rush Oak Park Hospital and Rush Health. Renowned Patient Care Rush University Medical Center encompasses a 664-bed hospital serving adults and children, including the Johnston R. Bowman Health Center, which provides medical and rehabilitative care to older adults and people with short- and long-term disabilities. It includes Rush's 376-bed Tower hospital building, which opened in 2012 as part of the Medical Center's major campus renovation. Rush's commitment to sustainability innovation earned the Tower LEED Gold certification. It is the largest new construction health care project in the world to be LEED Gold certified. Rush's renovation also includes Rush's Orthopedic Building, which opened in 2010, and the ongoing campuswide implementation of an electronic medical record system, enhancing patient care and safety. A unique combination of research and patient care has earned Rush national rankings in 11 of 16 specialty areas in U.S. News & World Report's 2012-13 America's Best Hospitals issue, among other recognitions of our quality of care and accreditations. Our nurses are at the forefront of our efforts to provide quality care, receiving Magnet status three times for making outstanding nursing care the standard at the Medical Center. Rush was the first hospital in Illinois serving adults and children to receive Magnet status — the highest honor in nursing — and the first in Illinois to earn a third four-year designation. And some of the world’s best athletes trust themselves to the hands of our physicians. Rush is proud to be the preferred hospital for the Chicago Bulls and home to the team physicians for both the Chicago Bulls and the Chicago White Sox.

Chair, Department of Pathology
Current

Rush Medical College is a school.

Operating Partner
Current

Shore Capital Partners focuses on investments in lower middle-market companies in the healthcare sector. For platform investments, the firm targets companies focused on microcap healthcare and food & beverage investments with $5 million to $50 million and EBITDA of $1 million to $5 million. For add-on investments, companies should have at least $1 million in revenues. There is no minimum EBITDA requirement. Shore Capital Partners participates in: family succession transactions, MBOs, LBOs, recapitalizations, industry consolidations, growth investments and corporate divestitures.

Boards & Committees
Director
2007 - Current
Director
1992 - Prior
Member, Executive Committee
1991 - Prior
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Robert DeCresce. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Robert DeCresce's profile does not indicate a business or promotional relationship of any kind between RelSci and Robert DeCresce.